P104 White Coat Hypertension is Associated with Increased Small Vessel Disease in the Brain

P104 White Coat Hypertension is Associated with Increased Small Vessel Disease in the Brain

Objective: Small vessel disease, measured by brain white matter hyperintensity (WMH), is associated with increased stroke risk and cognitive impairment. This study aimed to explore the relationship between WMH on computerised tomography (CT) and white coat hypertension (WCH) in patients with recent...

Full description

Bibliographic Details
Main Authors:	Fran Kirkham, E Drazich, A Vundavalli, P Rankin, J Timeyin, E Bunting, K Ali, C Rajkumar
Format:	Article
Language:	English
Published:	Atlantis Press 2020-02-01
Series:	Artery Research
Online Access:	https://www.atlantis-press.com/article/125934584/view

Similar Items

P116 Post-stroke White Coat Hypertension/Effect is Associated with Greater Arterial Stiffness
by: Fran Kirkham, et al.
Published: (2020-02-01)

P115 Does Post-stroke White Coat Hypertension/Effect (WCH/E) Require Intensive Blood Pressure Management?
by: Fran Kirkham, et al.
Published: (2020-02-01)

C-Reactive Protein Predicts Further Ischemic Events in Patients With Transient Ischemic Attack or Lacunar Stroke
by: Manuela Mengozzi, et al.
Published: (2020-07-01)

Current status of white coat hypertension: where are we?
by: Gani Nuredini, et al.
Published: (2020-06-01)

WHITE COAT EFFECT AND WHITE COAT HYPERTENSION: ONE AND THE SAME?
by: TENG CL, et al.
Published: (2008-01-01)

White-coat hypertension and masked hypertension: an update
by: Nathan Artom, et al.
Published: (2015-10-01)

8.11 CARDIO-ANKLE VASCULAR INDEX AND CAROTID-FEMORAL PULSE WAVE VELOCITY ARE CLOSELY ASSOCIATED WITH CHRONOLOGICAL AGE
by: L.B. Mendes, et al.
Published: (2016-11-01)

Complications of white-coat hypertension compared to a normotensive and hypertensive population
by: Ziad Abdullah Taher, et al.
Published: (2021-01-01)

CONTEMPORARY PROBLEMS OF EVALUATION OF HYPERTENSION TREATMENT EFFICACY: MASKED HYPERTENSION AND WHITE COAT HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

CONTEMPORARY PROBLEMS OF EVALUATION OF HYPERTENSION TREATMENT EFFICACY: MASKED HYPERTENSION AND WHITE COAT HYPERTENSION
by: V. M. Gorbunov, et al.
Published: (2016-01-01)

Brain White Matter: A Substrate for Resilience and a Substance for Subcortical Small Vessel Disease
by: Farzaneh A. Sorond, et al.
Published: (2019-08-01)

Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats
by: Fujita, Youshi
Published: (2010)

P30 THE ROLE OF NOVEL BIOMARKERS IN ARTERIAL STIFFNESS, AND IN PREDICTING FURTHER VASCULAR EVENTS AFTER TIA AND LACUNAR STROKE
by: Esme Girdwood, et al.
Published: (2017-12-01)

A104
by: V. Rybko, et al.
Published: (2015-11-01)

P.079 PULSE WAVE VELOCITY IN SUBJECTS WITH MASKED HYPERTENSION AND WHITE COAT HYPERTENSION
by: K. Stolarz*, et al.
Published: (2007-06-01)

The combined presence of hypertension and vitamin D deficiency increased the probability of the occurrence of small vessel disease in China
by: Junzeng Si, et al.
Published: (2019-07-01)

White matter integrity and structural brain network topology in cerebral small vessel disease: The Hamburg city health study
by: Borof, K., et al.
Published: (2021)

Prevalence of Masked and White-Coat Hypertension in Pre-Hypertensive and Stage 1 Hypertensive patients with the use of TeleMRPA
by: Weimar Kunz Sebba Barroso, et al.

Association of parathyroid hormone and vitamin D with untreated hypertension: Is it different in white-coat or sustained hypertension?
by: Ferit Akgül, et al.
Published: (2017-01-01)

Abnormal brain white matter microstructure is associated with both pre-hypertension and hypertension.
by: Hideaki Suzuki, et al.
Published: (2017-01-01)

White matter changes and gait decline in cerebral small vessel disease
by: H.M. van der Holst, et al.
Published: (2018-01-01)

Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study.
by: Heba Alwan, et al.
Published: (2014-01-01)

Evaluation of white coat hypertension in Chinese children : predictive factors and outcome
by: Chow, Chin-ying, et al.
Published: (2014)

Spiritan News 104
by: Holy Ghost Fathers

P.060 AGE-RELATED ARTERIAL STIFFNESS IN PATIENTS WITH WHITE COAT OR ESSENTIAL HYPERTENSION
by: G. Vyssoulis*, et al.
Published: (2007-06-01)

White matter asymmetries in patients with cerebral small vessel disease
by: Hua Zhou, Yan Tang, Zhi Yuan
Published: (2018-05-01)

White matter integrity in small vessel disease is related to cognition
by: Anil M. Tuladhar, et al.
Published: (2015-01-01)

Blood Vessel Structure in Hypertension
by: Irving R, et al.
Published: (1999-01-01)

P1.04 DETERMINATION OF BOTH NEAR AND FAR WALL BEHAVIOUR OF THE CAROTID ARTERY IN HYPERTENSIVE AND NORMOTENSIVE SUBJECTS
by: H. Beaussier, et al.
Published: (2010-12-01)

INCREASED STRESS-REACTIVITY OF MALES WITH HIGH NORMAL BLOOD PRESSURE AND HYPERTENSION: INFLUENCE ON THE VESSELS
by: O. N. Antropova, et al.
Published: (2017-05-01)

The Story of White Coats and Small Miracles
by: Magdalena Picz
Published: (2020-01-01)

Cognitive and autonomic dysfunction measures in normal controls, white coat and borderline hypertension
by: Shehab Abdullah, et al.
Published: (2011-01-01)

Cardiovascular Alterations and Management of Patients With White Coat Hypertension: A Meta-Analysis
by: Huaqiang Xiang, et al.
Published: (2020-09-01)

P.074 EFFECT OF SMOKING ON ARTERIAL STIFFNESS IN PATIENTS WITH WHITE COAT HYPERTENSION
by: S.-M. Kyvelou, et al.
Published: (2007-08-01)

White coat hypertension: improving the patient–health care practitioner relationship
by: Cobos B, et al.
Published: (2015-05-01)

BOLD fMRI in the white matter as a marker of aging and small vessel disease.
by: Ilia Makedonov, et al.
Published: (2013-01-01)

White-coat hypertension and normotension in the League of Hypertension of the Hospital das Clínicas, FMUSP: prevalence, clinical and demographic characteristics
by: Carlos A. Segre, et al.
Published: (2003-02-01)

Treatment of White Coat HYpertension in the Very Elderly Trial (HYVET 2) - Feasibility of a Randomized Controlled Trial (Study Protocol)
by: Michael Okorie, et al.
Published: (2019-11-01)

Haydn Symphony No.104 「London」
by: Chien Wen Hung, et al.
Published: (2011)

The Impact of Different Anthropometric Measures on Sustained Normotension, White Coat Hypertension, Masked Hypertension, and Sustained Hypertension in Patients with Type 2 Diabetes
by: Baris Afsar
Published: (2013-09-01)

Cannot write session to /tmp/vufind_sessions/sess_sghhvt8thms56dab9skkgs4t4f